SciELO - Scientific Electronic Library Online

 
vol.5 número3Estudio SHIFT: (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) Un CAMBIO en el tratamiento de la insuficiencia cardíaca¿Qué hacer cuando la anemia se interpone en la insuficiencia cardíaca crónica? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Insuficiencia cardíaca

versión On-line ISSN 1852-3862

Resumen

CEREZO, Gustavo H. Metabolic syndrome: What should we know about metabolic syndrome in our daily practice?. Insuf. card. [online]. 2010, vol.5, n.3, pp.137-143. ISSN 1852-3862.

Metabolic syndrome (MS) or insulin resistance syndrome is a pathological entity that has caught the attention of many scientists from different specialties within the last two decades. This clinical setting, which is characterized by a constellation of risk factors for cardiovascular disease and the development of diabetes mellitus type two, has a high prevalence worldwide and it is growing. The MS has generated lots of controversy regarding its classification, cutoff point of its variables, physiopathology and prevalence in different populations, which still persist today. This synthetic review aims to bring essential knowledge to practitioners about a clinical setting with a great epidemiological and individual importance, in order to assist our patients to break the vicious circle that represents the MS, because if this does not happen, our patients sooner or later result in severe complications that compromise their quality and quantity of life.

Palabras clave : Metabolic syndrome; Insulin resistance syndrome; Risk factors; Cardiovascular disease; Diabetes mellitus type 2.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons